Papers/PMID:23039299
Randomised trial of magnesium in the treatment of Irukandji syndrome.
Emergency medicine Australasia : EMA2012The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
magnesium(2+) — no detected effect on hospital length of stay
Evidence strength: very limited.FindingNull resultreplicated ×2“There was no significant difference in the morphine equivalent dose used, peak CK, peak troponin, peak pulse, peak blood pressure, peak mean arterial pressure (MAP), percentage MAP rise and length of stay for those receiving magnesium compared with placebo.”
Quoted verbatim from Randomised trial of magnesium in the treatment of Irukandji syndrome.. - Study
- RCT
- Dose
- 10 mmol magnesium bolus then 5 mmol/h infusion for 6 h
- Population
- Patients with Irukandji syndrome requiring parenteral opioid analgesia; secondary outcome
Randomised trial of magnesium in the treatment of Irukandji syndrome.2012PMID:2303929910.1111/j.1742-6723.2012.01602.xPermalink